MedPath

TO STUDY THE EFFECTS AUTOIMPLANFATION VERSUS BCG VACCINE IN PATIENTS OF WARTS

Phase 4
Conditions
Health Condition 1: null- RECURRENT,RECALCITRANT, WARTS - 5 OR MORE THAN 5 IN NO.
Registration Number
CTRI/2017/03/008083
Lead Sponsor
Department of Dermatology Venereology and Leprosy
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Open to Recruitment
Sex
Not specified
Target Recruitment
0
Inclusion Criteria

Number of warts five or more than five

Recurrent warts at same site

Recalcitrant wart to various treatment modalities

Exclusion Criteria

Pregnancy

Lactation

Immunosuppression due to drugs or disease,

Advanced disease of vital organs like stroke cancer cardiovascular disease renal disease diabetes mellitus

•Patient not willing to participate in the study

•Inability to come for monthly follow up,

Study & Design

Study Type
Interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
umber Of warts <br/ ><br>percentage of reduction in number Of warts <br/ ><br>Timepoint: 0 month first month second month third month <br/ ><br>
Secondary Outcome Measures
NameTimeMethod
patient self assessment scoreTimepoint: 0 month, first month,second month, third month
© Copyright 2025. All Rights Reserved by MedPath